BAX
Baxter International Inc
Baxter International Inc historical holders
total: 13
Third Point Baxter International Inc transactions over time
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 9
- Held since:
- 2015 Q2
- Held for:
- 21 quarters
- Latest activity:
- 2020 Q3
Daniel Loeb has been an institutional investor in Baxter International Inc (BAX) since 2015 Q2. According to 2026 Q1 report, Daniel Loeb doesn't hold any shares. The fund/company first acquired BAX in 2015 Q2, initially purchasing about 3.95M shares. Since the initial investment, Third Point has made 12 more transactions in this position.
When did Daniel Loeb exit their BAX position?
Daniel Loeb no longer holds Baxter International Inc (BAX). They sold off their entire position in 2020 Q3, closing out an investment that began in 2015 Q2.
When did Daniel Loeb first invest in BAX?
Daniel Loeb first invested in Baxter International Inc (BAX) in 2015 Q2 at the reported quarter-end price of $69.93 per share, acquiring 3,950,000 shares in their initial purchase.
What is Daniel Loeb's average cost basis for BAX?
Based on historical transaction data, Daniel Loeb's estimated cost basis for Baxter International Inc (BAX) is approximately $36.14 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $36.14
- Weighted AVG sell price:
- $72.88
BAX transactions history by Third Point
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q3
|
0.00%
|
$86.10
|
-100% (-4,000,000)
|
|||
|
2020 Q2
|
4.71%
|
$86.10
|
-65.46% (-7,580,000)
|
|||
|
2020 Q1
|
15.00%
|
$81.19
|
-33.83% (-5,920,000)
|
|||
|
2019 Q4
|
16.83%
|
$83.62
|
+3.86% (+650,000)
|
|||
|
2019 Q3
|
17.51%
|
$87.47
|
-26.74% (-6,150,000)
|
|||
|
2019 Q2
|
22.06%
|
$81.90
|
-17.86% (-5,000,000)
|
|||
|
2018 Q4
|
28.32%
|
$65.82
|
-22.22% (-8,000,000)
|
|||
|
2017 Q4
|
17.25%
|
$64.64
|
-12.20% (-5,000,000)
|
|||
|
2017 Q2
|
22.00%
|
$60.54
|
-10.87% (-5,000,000)
|
|||
|
2017 Q1
|
23.51%
|
$51.86
|
-11.37% (-5,901,767)
|
|||
|
2016 Q2
|
22.62%
|
$45.22
|
-3.62% (-1,948,233)
|
|||
|
2015 Q3
|
17.05%
|
$32.85
|
+1,263.29% (+49,900,000)
|
|||
|
2015 Q2
|
2.71%
|
$69.93
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.